MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BDX — Becton, Dickinson and Co.
NYSEBecton, Dickinson and Co.
$176.80
-1.27(-0.71%)
- O
- 177.46
- H
- 178.13
- L
- 175.71
- V
- 1.85M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About BDX
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateSep 25, 1963
Employees72,000
Stock ExchangeNYSE
Ticker SymbolBDX
Websitehttps://www.bd.com
Key Financial Statistics
| Market Cap | $50.07B |
| P/E Ratio | N/A |
| Dividend Yield | 2.38% (Quarterly) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $127.59 - $193.07 |
| 52-Week Avg Volume | 2.56M |
| VWAP | $176.77 |
| Transactions | 30,259 |
| Total Recorded Bars | 13,517 days |